Microbiome milestone: MaaT Pharma and Clinigen team up to deliver innovative oncology therapy

Xervyteg® marks a major advance in microbiome therapeutics, with potential to become the first approved microbiota therapy in Europe.

Sacco System: advancing probiotic science from ingredients to innovation

Carlo Sala, Sales Director EMEA & LATAM - Microbiome BU at Sacco System, discusses the company innovative probiotic strains, tailored manufacturing services, and commitment to R&D.

A gut fungus may help protect against advanced liver disease

Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.

Study reveals how skin bacteria establish and persist over time

Certain barriers on the skin prevent easy colonization of new strains and specific life stages, such as adolescence, may be crucial for successful probiotic interventions.

World Microbiome Day: celebrating the invisible allies transforming health, business, and the planet

With the theme “Microbiome 101: What You Need to Know”, this year's WMD makes a bold and timely move: bringing microbiome science back to basics, and straight into the hands…

Danone Boosts Gut Health Innovation with Akkermansia Acquisition

Danone has announced the acquisition of The Akkermansia Company (TAC), significantly expanding its investment into gut health and next-generation biotic research.

Tiny differences in gut bacteria may influence health and disease

Even small differences between strains of gut bacteria—often within the same species—can sway how these microbes interact with the human body and influence disease outcomes.

Neonatal fungi promote metabolic health

A microbiota-mediated macrophage-dependent mechanism may be used to reduce diabetes incidence in vivo. 

SynBalance at Vitafoods 2025: shaping the future of longevity through targeted probiotic solutions

An interview to SynBalance Marketing Manager, Silva Castegnaro on the latest clinically backed solutions shaping the future of biotics world.

Genetic variant linked to colorectal cancer may boost tumor-associated bacteria

Genetic factors can influence tumor-associated microbes, offering insights into colorectal cancer progression and potential therapeutic targets.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top